Patents by Inventor Niels Cristoph RIEDEMANN

Niels Cristoph RIEDEMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-C5A binding moieties with high blocking activity
    Patent number: 9073983
    Abstract: The present invention relates to binding moieties that specifically bind to a conformational epitope of C5a, in particular human C5a. Preferred binding moieties are anti-C5a antibodies that bind to this conformational epitope. The binding moieties described herein are useful as active agents in pharmaceutical compositions for the treatment and prevention of various acute and chronic diseases, in particular acute inflammatory diseases, such as the systemic inflammatory response syndrome (SIRS), and different degrees of sepsis including sepsis, severe sepsis, and septic shock.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: July 7, 2015
    Assignee: INFLARX GMBH
    Inventors: Renfeng Guo, Niels Cristoph Riedemann, Yan Li, Beifen Shen
  • ANTI-C5A BINDING MOIETIES WITH HIGH BLOCKING ACTIVITY
    Publication number: 20140314772
    Abstract: The present invention relates to binding moieties that specifically bind to a conformational epitope of C5a, in particular human C5a. Preferred binding moieties are anti-C5a antibodies that bind to this conformational epitope. The binding moieties described herein are useful as active agents in pharmaceutical compositions for the treatment and prevention of various acute and chronic diseases, in particular acute inflammatory diseases, such as the systemic inflammatory response syndrome (SIRS), and different degrees of sepsis including sepsis, severe sepsis, and septic shock.
    Type: Application
    Filed: June 27, 2014
    Publication date: October 23, 2014
    Inventors: Renfeng GUO, Niels Cristoph RIEDEMANN, Yan LI, Beifen SHEN